Clover Biopharmaceutical

Feb 23, 2021

Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Jan 31, 2020

Wuhan Coronavirus: A global emergency

Newsletter/Whitepaper